We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSENS.L Regulatory News (SENS)

  • There is currently no data for SENS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of Results

20 Dec 2019 09:00

RNS Number : 6253X
Sensyne Health PLC
20 December 2019
 

 

 

 

Notice of Interim Results

 

Oxford, UK; 20 December 2019: Sensyne Health plc (LSE: SENS), the British clinical AI technology company, will announce its Interim Results for the 6 months ended 31 October 2019 on Tuesday 21 January 2020.

 

Lord (Paul) Drayson, Chief Executive Officer, and Lorimer Headley, Chief Financial Officer, will host a briefing for analysts at 12.00pm GMT on the day of the results at 1 Moorgate Place, London, EC2R 6EA.

 

A live webcast of the meeting, with the presentation slides, will be available via the Company's website.

 

 

-ENDS-

 

 

For more information please contact:

 

Sensyne Health (www.sensynehealth.com)

+44 (0) 330 058 1845

Lord (Paul) Drayson, Chief Executive Officer

 

Lorimer Headley, Chief Financial Officer

 

 

 

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+ 44 (0) 20 7418 8900

Dr Christopher Golden

 

James Steel

 

Oliver Jackson

 

 

 

 

Liberum (Joint Broker)

+ 44 (0) 20 3100 2000

Bidhi Bhoma

 

Euan Brown

 

 

 

Consilium Strategic Communications

+44 20 3709 5700

Mary-Jane Elliott

 

Sukaina Virji

 

Melissa Gardiner

 

sensynehealth@consilium-comms.com

 

 

 

About Sensyne Health

Sensyne Health plc is a clinical AI company that works in partnership with the NHS to improve patient care and accelerate the discovery and development of new medicines. Sensyne Health is listed on the AIM Market of the London Stock Exchange (SENS.L). For more information, please visit: www.sensynehealth.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NORVBLBLKLFXFBL
Date   Source Headline
20th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
20th Jan 202211:31 amRNSForm 8.5 (EPT/RI)- Sensyne Health plc
20th Jan 20229:10 amRNSForm 8.5 (EPT/RI)
19th Jan 202212:42 pmGNWInvesco Ltd.: Form 8.3 - Sensyne Health Plc.
19th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
19th Jan 20228:36 amRNSForm 8.5 (EPT/RI)
18th Jan 20222:55 pmGNWInvesco Ltd. Form 8.3 Sensyne Health Plc
18th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
18th Jan 202211:17 amRNSForm 8.5 (EPT/RI)- Sensyne Health plc
18th Jan 20228:56 amRNSForm 8.5 (EPT/RI)
18th Jan 20227:00 amRNSHoldings in Company
17th Jan 20223:00 pmBUSForm 8.3 - Sensyne Health plc
17th Jan 202212:46 pmGNWForm 8.3 - Octopus Investments - Sensyne Health plc
17th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
17th Jan 20229:24 amRNSForm 8.3 - Sensyne Health Plc
17th Jan 20229:04 amRNSForm 8.5 (EPT/RI)
14th Jan 20222:53 pmRNSForm 8.3 - Sensyne Health plc
14th Jan 20222:05 pmRNSSecond Price Monitoring Extn
14th Jan 20222:00 pmRNSPrice Monitoring Extension
14th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
14th Jan 202211:08 amRNSForm 8.5 (EPT/RI)- Sensyne Health plc
14th Jan 20229:05 amRNSSecond Price Monitoring Extn
14th Jan 20229:00 amRNSPrice Monitoring Extension
14th Jan 20228:58 amRNSForm 8.5 (EPT/RI)
14th Jan 20227:00 amRNSUpdate on Trading, FSP & Proposed Financing
13th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
13th Jan 20229:58 amRNSForm 8.5 (EPT/RI)
12th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
12th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
12th Jan 202211:27 amRNSForm 8.3 - Sensyne Health plc
12th Jan 20229:11 amRNSForm 8.5 (EPT/RI) - Sensyne Health PLC
11th Jan 202211:24 amRNSForm 8.5 (EPT/RI)- Sensyne Health plc
11th Jan 20229:08 amRNSForm 8.5 (EPT/RI)
10th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
10th Jan 202211:22 amRNSForm 8.5 (EPT/RI)- Sensyne Health plc
10th Jan 20229:56 amRNSForm 8.3 - Sensyne Health Plc
10th Jan 20229:28 amRNSForm 8.5 (EPT/RI)
7th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
6th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
5th Jan 202211:09 amRNSForm 8.5 (EPT/RI)- Sensyne Health plc
5th Jan 20229:11 amRNSForm 8.5 (EPT/RI)
5th Jan 20227:24 amRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
4th Jan 202212:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
30th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
30th Dec 20218:44 amRNSForm 8.5 (EPT/RI)
29th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
29th Dec 20218:45 amRNSForm 8.5 (EPT/RI)
24th Dec 202112:00 pmRNSForm 8.5 (EPT/RI) - Sensyne Health Plc
24th Dec 202111:19 amRNSForm 8.5 (EPT/RI)-Sensyne Health plc
24th Dec 202111:09 amRNSForm 8.3 - Sensyne Health plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.